Search form

You are here

Home » Annual Conference

Abstract Submission

Conference Banner

We invite submissions of abstracts of no more than 250 words for presentation (oral or poster) at the NLCFN annual conference. Abstracts can be on any subject of relevant to lung cancer nurse specialists working in the lung cancer/mesothelioma field. Abstracts can be on a clinical area or based on a project affecting service delivery, LCNS education or palliative care. Abstracts can be based on academic research, audit results or best practice.

Accepted abstracts meeting the criteria for publication will be published on the website and  the conference app. All abstracts submitted will be reviewed by the committee. The abstract achieving the highest reviewer score will be invited to be presented in the main conference plenary session. The deadline for submissions is 13 September.

Abstracts previously presented at national/international lung cancer conferences considered.

View the presentation on preparing an abstract for help or contact us via info@nlcfn.net if you have questions.

Your Details
Abstract Information
Please list all other authors involved in the abstract in order using the format last name in full then first name initials and separate each author's name with a semi-colon.
Please enter your abstract content below (excluding title, authors and affiliations). Maximum 250 words. Do not include tables or figures or any other formatting. When submitting audit, research or service evaluation project findings please adopt the following structure to your abstract - Aim, design, setting, sample, data collection, data analysis, findings, implications for policy or practice.
I/we consent to my/our abstract being published online and on the conference app as part of the proceedings of this conference if selected. NB Only abstracts which have not previously been published (or accepted for publication) can be published in conference proceedings.
I/we consent to my/our poster being published on the conference app and online as part of the proceedings of this conference if selected.

We're grateful for sponsorship from those companies listed for supporting this event including our Platnimun Sponsors AstraZeneca, MSD, and Roche. For a full list of all sponsors please see our sponsors page. Read our statement on commercial funding for more information.

AstraZeneca Logo  MSD Logo   Roche Logo        Takeda Logo